Recchioni T, Manzi G, Mihai A, Adamo F, Caputo A, Filomena D
Int J Cardiol Congenit Heart Dis. 2025; 19:100568.
PMID: 39911953
PMC: 11795067.
DOI: 10.1016/j.ijcchd.2025.100568.
Giudice F, Escribano-Subias P, Tello K, Kopec G, Ghio S, Giannakoulas G
Eur Heart J Imaging Methods Pract. 2025; 3(1):qyae121.
PMID: 39816928
PMC: 11733976.
DOI: 10.1093/ehjimp/qyae121.
Hemnes A, Celermajer D, DAlto M, Haddad F, Hassoun P, Prins K
Eur Respir J. 2024; 64(4).
PMID: 39209482
PMC: 11525331.
DOI: 10.1183/13993003.01321-2024.
Dardi F, Boucly A, Benza R, Frantz R, Mercurio V, Olschewski H
Eur Respir J. 2024; 64(4).
PMID: 39209472
PMC: 11525341.
DOI: 10.1183/13993003.01323-2024.
Lokhorst C, van der Werf S, Berger R, Douwes J
J Am Heart Assoc. 2024; 13(13):e034151.
PMID: 38904230
PMC: 11255703.
DOI: 10.1161/JAHA.123.034151.
Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension.
Rischard F, Bernardo R, Vanderpool R, Kwon D, Acharya T, Park M
Circ Heart Fail. 2023; 16(10):e010555.
PMID: 37664964
PMC: 10592283.
DOI: 10.1161/CIRCHEARTFAILURE.123.010555.
Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension.
Caccamo M, Harrell F, Hemnes A
Pulm Circ. 2023; 13(3):e12271.
PMID: 37554146
PMC: 10405062.
DOI: 10.1002/pul2.12271.
Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Caputo A, Papa S, Manzi G, Laviola D, Recchioni T, Severino P
Curr Heart Fail Rep. 2023; 20(4):263-270.
PMID: 37486563
PMC: 10421820.
DOI: 10.1007/s11897-023-00612-2.
Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review.
Lokhorst C, van der Werf S, Berger R, Douwes J
Front Cardiovasc Med. 2022; 9:1035453.
PMID: 36440049
PMC: 9684185.
DOI: 10.3389/fcvm.2022.1035453.
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension.
Badagliacca R, DAlto M, Ghio S, Argiento P, Brunetti N, Casu G
ERJ Open Res. 2022; 8(4).
PMID: 36382240
PMC: 9638831.
DOI: 10.1183/23120541.00298-2022.
Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Benza R, Langleben D, Hemnes A, Vonk Noordegraaf A, Rosenkranz S, Thenappan T
Eur Respir Rev. 2022; 31(166).
PMID: 36198418
PMC: 9724805.
DOI: 10.1183/16000617.0061-2022.
Comment on Topyła-Putowska et al. Echocardiography in Pulmonary Arterial Hypertension: Comprehensive Evaluation and Technical Considerations. 2021, , 3229.
Manzi G, Vizza C, Badagliacca R
J Clin Med. 2022; 11(12).
PMID: 35743408
PMC: 9224639.
DOI: 10.3390/jcm11123337.
Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension.
Manzi G, Papa S, Mariani M, Scoccia G, Filomena D, Malerba C
Vascul Pharmacol. 2022; 145:107024.
PMID: 35716991
PMC: 9212864.
DOI: 10.1016/j.vph.2022.107024.
Regular Risk Assessment in Pulmonary Arterial Hypertension - A Whistleblower for Hidden Disease Progression.
Wu S, Wu Y
Acta Cardiol Sin. 2022; 38(2):113-123.
PMID: 35273432
PMC: 8888324.
DOI: 10.6515/ACS.202203_38(2).20211005A.
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?.
Vizza C, Lang I, Badagliacca R, Benza R, Rosenkranz S, White R
Am J Respir Crit Care Med. 2021; 205(7):751-760.
PMID: 34905704
PMC: 9836222.
DOI: 10.1164/rccm.202109-2079PP.
The Growing Role of Echocardiography in Pulmonary Arterial Hypertension Risk Stratification: The Missing Piece.
Miotti C, Papa S, Manzi G, Scoccia G, Luongo F, Toto F
J Clin Med. 2021; 10(4).
PMID: 33561999
PMC: 7915820.
DOI: 10.3390/jcm10040619.
Reply to Weatherald : Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?.
Badagliacca R, DAlto M, Ghio S, Vizza C, Naeije R
Am J Respir Crit Care Med. 2020; 203(4):525-526.
PMID: 33105086
PMC: 7885839.
DOI: 10.1164/rccm.202010-3834LE.
